Showing results (231-240 of 241) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, J Beyer, et al.
Leukemia|July 26, 2012
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemiaM Konantz, M C André, M Ebinger, et al.
Bone Marrow Transplantation|February 21, 2007
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myelomaM Schmidt-Hieber, I W Blau, R Trenschel, et al.
Bone Marrow Transplantation|September 4, 2003
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaH Einsele, M Bamberg, W Budach, et al.
Leukemia|February 14, 2015
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IVL Kalmanti, S Saussele, M Lauseker, et al.
Bone Marrow Transplantation|July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cellsH D Ottinger, E Albert, R Arnold, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
Leukemia|May 7, 2014
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinibB Hanfstein, V Shlyakhto, M Lauseker, et al.
Leukemia|March 27, 2012
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)B Hanfstein, M C Müller, R Hehlmann, et al.
The New England Journal of Medicine|August 10, 2012
Treatment of older patients with mantle-cell lymphomaH C Kluin-Nelemans, E Hoster, O Hermine, et al.
Pageof 25